All companies › TENX

TENX · TENAX THERAPEUTICS, INC.

Everything on this page is public record — SEC Form 4 filings and congressional disclosures — alongside any INSIDER SCANNER research case for this company.

Open-market buys14
Open-market sells0
Total purchased$6,396,477
Unique insiders buying5
Most senior buyerCEO
Avg price paid$1.73
Research cases0
Last filing2026-10-21

Average price paid is weighted by shares, so a large purchase counts for more than a small one. It is what insiders reported paying, not a target or a fair value.

Insider flow: Buying only — a count of disclosed transactions, not a rating or a recommendation.

Insider transaction timeline

Every reported transaction, positioned by trade date. Purchases sit above the axis, sales below; circle area is proportional to dollar value. No share-price line is drawn — this feed carries transaction prices only, and a price history inferred from them would imply market data the filings do not contain.

Open-market purchase Open-market sale
2026-08-20 — Schneeberger Daniel · bought 202,124 @ $1.78 2026-08-21 — Schneeberger Daniel · bought 716,369 @ $1.77 2026-08-24 — Schneeberger Daniel · bought 107,374 @ $1.75 2026-08-31 — Schneeberger Daniel · bought 403,571 @ $1.79 2026-09-01 — Schneeberger Daniel · bought 179,058 @ $1.80 2026-09-02 — Schneeberger Daniel · bought 187,704 @ $1.80 2026-09-03 — Schneeberger Daniel · bought 900,000 @ $1.78 2026-09-11 — Giordano Christopher Thomas · bought 6,000 @ $1.88 2026-09-11 — STAAB THOMAS R II · bought 5,675 @ $1.94 2026-09-15 — Giordano Christopher Thomas · bought 4,850 @ $1.82 2026-09-16 — Doogan Declan · bought 53,000 @ $1.92 2026-10-19 — ADAR1 Capital Management, LLC · bought 336,528 @ $1.51 2026-10-20 — ADAR1 Capital Management, LLC · bought 254,342 @ $1.60 2026-10-21 — ADAR1 Capital Management, LLC · bought 331,979 @ $1.66
2026-08-202026-10-21

Insider cost basis

Share-weighted average price across 14 reported purchases, with the full range of prices paid. Purchases only — averaging a sale into an "insider cost" would describe a price nobody paid.

$1.51 $1.94
$1.73 weighted average insider purchase price

Insider participation

One row per insider, one cell per reported transaction, shaded by value. Repeat buying and activity clustered in time are visible at a glance.

Schneeberger Daniel 10% owner
ADAR1 Capital Management, LLC 10% owner
Giordano Christopher Thomas CEO, Director
STAAB THOMAS R II Chief Financial Officer
Doogan Declan Director
Included with a free account

The analysis built on top of these filings

The filings above are public record and stay public here. What an account adds for $TENX is the reading of them — and for this company, that is what the list below says it is, no more.

  • Insider cost basisShare-weighted average price paid across the 14 reported purchases, with the full range, against the current price.
  • Insider participationWho bought, how often, and how the buying is distributed across the people filing — one person repeating is not several agreeing.
  • Transaction timelineThe [{'transaction_date': '2026-10-21', 'insider_name': 'ADAR1 Capital Management, LLC', 'insider_title': '10% owner', 'transaction_type': 'Open-market buy', 'shares': 331979.0, 'price': 1.6588, 'value': 550686.77, 'is_buy': True}, {'transaction_date': '2026-10-20', 'insider_name': 'ADAR1 Capital Management, LLC', 'insider_title': '10% owner', 'transaction_type': 'Open-market buy', 'shares': 254342.0, 'price': 1.5952, 'value': 405726.36, 'is_buy': True}, {'transaction_date': '2026-10-19', 'insider_name': 'ADAR1 Capital Management, LLC', 'insider_title': '10% owner', 'transaction_type': 'Open-market buy', 'shares': 336528.0, 'price': 1.5066, 'value': 507013.08, 'is_buy': True}, {'transaction_date': '2026-09-16', 'insider_name': 'Doogan Declan', 'insider_title': 'Director', 'transaction_type': 'Open-market buy', 'shares': 53000.0, 'price': 1.92, 'value': 101760.0, 'is_buy': True}, {'transaction_date': '2026-09-15', 'insider_name': 'Giordano Christopher Thomas', 'insider_title': 'CEO, Director', 'transaction_type': 'Open-market buy', 'shares': 4850.0, 'price': 1.8221, 'value': 8837.18, 'is_buy': True}, {'transaction_date': '2026-09-11', 'insider_name': 'Giordano Christopher Thomas', 'insider_title': 'CEO, Director', 'transaction_type': 'Open-market buy', 'shares': 6000.0, 'price': 1.875, 'value': 11250.0, 'is_buy': True}, {'transaction_date': '2026-09-11', 'insider_name': 'STAAB THOMAS R II', 'insider_title': 'Chief Financial Officer', 'transaction_type': 'Open-market buy', 'shares': 5675.0, 'price': 1.935, 'value': 10981.12, 'is_buy': True}, {'transaction_date': '2026-09-03', 'insider_name': 'Schneeberger Daniel', 'insider_title': '10% owner', 'transaction_type': 'Open-market buy', 'shares': 900000.0, 'price': 1.78, 'value': 1602000.0, 'is_buy': True}, {'transaction_date': '2026-09-02', 'insider_name': 'Schneeberger Daniel', 'insider_title': '10% owner', 'transaction_type': 'Open-market buy', 'shares': 187704.0, 'price': 1.8, 'value': 337867.2, 'is_buy': True}, {'transaction_date': '2026-09-01', 'insider_name': 'Schneeberger Daniel', 'insider_title': '10% owner', 'transaction_type': 'Open-market buy', 'shares': 179058.0, 'price': 1.8, 'value': 322304.4, 'is_buy': True}, {'transaction_date': '2026-08-31', 'insider_name': 'Schneeberger Daniel', 'insider_title': '10% owner', 'transaction_type': 'Open-market buy', 'shares': 403571.0, 'price': 1.79, 'value': 722392.09, 'is_buy': True}, {'transaction_date': '2026-08-24', 'insider_name': 'Schneeberger Daniel', 'insider_title': '10% owner', 'transaction_type': 'Open-market buy', 'shares': 107374.0, 'price': 1.75, 'value': 187904.5, 'is_buy': True}, {'transaction_date': '2026-08-21', 'insider_name': 'Schneeberger Daniel', 'insider_title': '10% owner', 'transaction_type': 'Open-market buy', 'shares': 716369.0, 'price': 1.77, 'value': 1267973.13, 'is_buy': True}, {'transaction_date': '2026-08-20', 'insider_name': 'Schneeberger Daniel', 'insider_title': '10% owner', 'transaction_type': 'Open-market buy', 'shares': 202124.0, 'price': 1.78, 'value': 359780.72, 'is_buy': True}] reported transactions plotted over the window rather than listed, so concentration is visible.

Not available for TENX today: no research case — nothing here has cleared the scoring threshold. Both appear on this page on their own if that changes.

A free account opens all of it.

Not financial advice. This page reports public filings and past research output. It is not a recommendation to buy or sell, and no price target here is a prediction. Trade at your own risk.